Dr Amatul Basit Khalid, MD | |
124 Sleepy Hollow Dr Ste 203, Middletown, DE 19709-5838 | |
(302) 449-3030 | |
(302) 449-3040 |
Full Name | Dr Amatul Basit Khalid |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Location | 124 Sleepy Hollow Dr Ste 203, Middletown, Delaware |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205890258 | NPI | - | NPPES |
1013618880002 | Medicaid | PA | |
093350G0D | Other | PA | PIN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | MD063751L (Pennsylvania) | Secondary |
207R00000X | Internal Medicine | MD063751L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Amatul Basit Khalid, MD 124 Sleepy Hollow Dr Ste 203, Middletown, DE 19709-5838 Ph: (302) 449-3030 | Dr Amatul Basit Khalid, MD 124 Sleepy Hollow Dr Ste 203, Middletown, DE 19709-5838 Ph: (302) 449-3030 |
News Archive
Post-partum haemorrhage (PPH) immediately after giving birth is the largest threat to new mothers in high-income countries.
Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular ("wet") Age-related Macular Degeneration (AMD).
The drug Hydroxychloroquine has long been studied as a treatment for malaria and autoimmune diseases. When the coronavirus pandemic spread across the globe, many countries resorted to using the drug in the hopes that it would improve outcomes of hospitalized patients affected by the coronavirus disease (COVID-19).
Dr. Bruce Bode announced today that he is now recruiting adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes.
› Verified 3 days ago
Dr. William Ray Lynch Jr., M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 212 Abbotsford Dr, Middletown, DE 19709 Phone: 302-319-4736 | |
Dr. Beth Anne Renzulli, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 102 Sleepy Hollow Dr Ste 200, Middletown, DE 19709 Phone: 302-449-0070 Fax: 302-613-7548 | |
Jay Rajnikant Patel, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 114 Sandhill Dr Ste 203, Middletown, DE 19709 Phone: 302-623-1929 Fax: 302-376-4350 | |
Christine Egan Metzing, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 413 Meadow Lane, Middletown, DE 19709 Phone: 302-376-5148 | |
Neilay Dedhia, Internal Medicine Medicare: Medicare Enrolled Practice Location: 114 Sandhill Dr Ste 101, Middletown, DE 19709 Phone: 302-378-4779 Fax: 302-378-4789 | |
Dr. William Covell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 212 Carter Dr, Suite A, Middletown, DE 19709 Phone: 302-378-4407 Fax: 302-378-4610 |